Crestor
A statin drug by AstraZeneca, Crestor, reduced the risk of heart-related death, attacks, and problems by 44% compared to a placebo. This will probably change the health strategy employed over the last ten years.
Dell
Compared to its competitors, Dell is late with new products.
Radio
Radio Stations have been historically durable in both up and down times. But, now after a 18-year consolidation period which left many radio companies heavy with debt, the sector is out of favor — its ad revenue is being squeezed. Valuations are at fire-sale levels.
